REGNCommon stockNASDAQ
REGN Common stock
This is the ticker-level security page. The issuer is Regeneron Pharmaceuticals.
Security details
Issuer financial context
These figures belong to the issuer company, not to this security itself.
Revenue TTM
$14.2B
Net income TTM
$4.6B
Total assets
$40.2B
Total debt
$2B
Total equity
$31B
Profit margin
32.1%
ROE
14.8%
ROA
11.4%
Latest issuer financial snapshot: 2024-12-31